Title: IMMUNOTHERAPY OF BLADDER CANCER TARGETING
P53 Abstract: Hyclone Laboratories, Inc., Logan, UH), 100U/ml.
penicillin, 100 g./ml. streptomycin and 2 mM L-glutamine. The HLA
status (A2.1 + or -) of each cell line was determined by polymerase
chain reaction (PCR) on genomic DNA using the primers 5
GGTCCCCAGGTCCACTCG-GTG3 and 5 CTCGTCCCCAGGCTCTCACTCC3 . Surface HLA
A2.1 expression was confirmed by indirect immunofluorescence (IF)
using the... Source: Journal of Urology http://webmedlit.silverplatter.com/j/381cf62628/